Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY AI Verdict: PROCEED
Price: $305.41 Analyst target: $342.29 Upside: 12.08%
CI broke out on the weekly chart to $306.95, a 52-week high (high 316.27), clearing 3m resistance at $304.69 and the 200-SMA at $300.15. MACD (2.36 vs. signal 0.07) is positive, news is Somewhat-Bullish (103 of 182 articles bullish) with Bernstein holding a $387 target, and insiders show cluster buying (~$3.0M bought vs. $0.9M sold, 2 distinct buyers). Valuation is cheap (forward P/E 8.3, PEG 0.75) and low beta (0.30) suits the defensive managed-care profile, though this is a momentum breakout, not an oversold dip.
Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g. governmental and non-governmental organizations, unions and associations).
See the full interactive analysis & chart →Informational only — not investment advice.